---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-072068"
form_type: "8-K"
ticker: "HOTH"
cik: "0001711786"
company_name: "Hoth Therapeutics, Inc."
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:48:51.675523+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Hoth Therapeutics shareholders approve director re-election and plan amendment at 2025 annual meeting

## Summary
- All five director nominees (Knie, Sarnoff, Linsley, Pavell, Camarra) re-elected with strong support.
- Ratification of Withum as auditor for FY2025 approved: 4,559,052 for, 247,728 against.
- Amendment to 2022 Plan to increase share reserve from 1,091,317 to 3,091,317 shares approved.
- Advisory vote on 2024 executive compensation approved: 1,098,368 for, 265,965 against.
- Shareholders selected one-year frequency for future advisory votes on executive pay.

## SEC filing metadata
- accession: 0001213900-25-072068
- form_type: 8-K
- ticker: HOTH
- cik: 0001711786
- company_name: Hoth Therapeutics, Inc.
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711786/000121390025072068/0001213900-25-072068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711786/000121390025072068/ea0251896-8k_hoth.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-072068
- JSON: https://secwatch.observer/filing/0001213900-25-072068.json
- Plain text: https://secwatch.observer/filing/0001213900-25-072068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.